Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
30.49
+1.27 (4.35%)
Apr 17, 2026, 4:00 PM EDT - Market closed
Sensei Biotherapeutics Market Cap
Sensei Biotherapeutics has a market cap or net worth of $40.87 million as of April 17, 2026. Its market cap has increased by 369.89% in one year.
Market Cap
40.87M
Enterprise Value
21.19M
1-Year Change
369.89%
Ranking
Category
Stock Price
$30.49
Market Cap Chart
Since the IPO on February 4, 2021, Sensei Biotherapeutics's market cap has decreased from $561.61M to $40.87M, a decrease of -92.72%. That is a compound annual growth rate of -39.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 40.87M | 203.65% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.40% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daré Bioscience | 41.49M |
| Aligos Therapeutics | 41.27M |
| Actinium Pharmaceuticals | 40.22M |
| CEL-SCI | 39.66M |
| Veru Inc. | 38.68M |
| Lixte Biotechnology Holdings | 38.34M |
| Evaxion | 38.20M |
| Passage Bio | 37.92M |